Harvest Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Harvest Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $1 Million - $1.05 Million	6,900 Added 16.59%	48,503 $7.33 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $3.24 Million - $5.69 Million	38,970 Added 1480.06%	41,603 $6.06 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $291,712 - $378,737	-2,650 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $24,932 - $37,120	250 Added 10.42%	2,650 $365,000
Q3 2021 Nov 04, 2021	BUY	$98.85 - $138.91 $19,770 - $27,782	200 Added 9.09%	2,400 $333,000
Q2 2021 Jul 23, 2021	BUY	$65.78 - $105.02 $144,716 - $231,044	2,200 New	2,200 $214,000
Q1 2020 Apr 28, 2020	SELL	$27.51 - $57.29 $129,874 - $270,466	-4,721 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$40.86 - $57.65 $52,259 - $73,734	-1,279 Reduced 21.32%	4,721 $257,000
Q3 2019 Oct 30, 2019	SELL	$37.38 - $49.47 $370,062 - $489,753	-9,900 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$39.79 - $67.01 $393,921 - $663,399	9,900 New	9,900 $434,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Harvest Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Management LLC with notifications on news.